Immediate Impact
12 standout
Citing Papers
Recent progress of CDK4/6 inhibitors’ current practice in breast cancer
2024 Standout
Urease-powered nanobots for radionuclide bladder cancer therapy
2024 Standout
Works of Jelena Rascon being referenced
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma–LuDO-N
2022
Efficacy of maintenance therapy with zoledronic acid in patients with localized Ewing sarcoma: Report from the international Ewing 2008 trial.
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jelena Rascon | 66 | 50 | 46 | 59 | 40 | 259 | |
| L. Appaji | 65 | 45 | 73 | 77 | 44 | 278 | |
| Asmâa Quessar | 69 | 33 | 38 | 64 | 49 | 233 | |
| Benedikt Bernbeck | 81 | 38 | 44 | 65 | 26 | 231 | |
| Canan Vergin | 83 | 35 | 36 | 27 | 38 | 256 | |
| Parameswaran Anoop | 65 | 28 | 26 | 45 | 45 | 208 | |
| Gülsan Yavuz | 44 | 23 | 27 | 76 | 44 | 310 | |
| Stefano Giardino | 134 | 40 | 37 | 82 | 40 | 311 | |
| Khawar Siddiqui | 112 | 25 | 41 | 73 | 54 | 336 | |
| P. Kajtár | 47 | 75 | 79 | 58 | 30 | 296 | |
| Yasuhiro Ikawa | 82 | 25 | 26 | 33 | 46 | 281 |
All Works
Login with ORCID to disown or claim papers
Loading papers...